RT Journal Article
SR Electronic
A1 Buckely, Rita
T1 GH Replacement Improves CV Risk Factors in Viscerally Obese Premenopausal Women
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 5
SP 11
OP 12
DO 10.1177/155989771105006
UL http://mdc.sagepub.com/content/11/5/11.abstract
AB Effects of Growth Hormone on Body Composition and Cardiovascular Risk Markers in Women with Visceral Adiposity was a 6-month randomized, double-blind, placebo-controlled trial to determine whether low-dose GH administration would reduce abdominal adiposity and CV risk markers in premenopausal women with reduced GH secretion due to abdominal obesity.